Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statementWilson I. Gonsalves, Vivek Roy, S. R. Hayman et al.|Bone Marrow Transplantation|2018Cited by 116
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patientsPatrick Mellors, Angela Dispenzieri, Surendra Dasari et al.|Blood Cancer Journal|2021Cited by 47
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsRajshekhar Chakraborty, Morie A. Gertz, Eli Muchtar et al.|Bone Marrow Transplantation|2016Cited by 33
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Morie A. Gertz, Angela Dispenzieri et al.|Haematologica|2016Cited by 10